Bio/Data Corporation 代理

详细介绍

产品咨询

世界*实验材料供应商 Bio/Data Corporation上海金畔生物为其中国代理， Bio/Data Corporation在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，  Bio/Data Corporation就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 Bio/Data Corporation 中国代理, Bio/Data Corporation 上海代理， Bio/Data Corporation 北京代理，Bio/Data Corporation 广东代理， Bio/Data Corporation 江苏代理Bio/Data Corporation 湖北代理,Bio/Data Corporation天津,Bio/Data Corporation 黑龙江代理,Bio/Data Corporation  内蒙古代理,Bio/Data Corporation 吉林代理,Bio/Data Corporation 福建代理, Bio/Data Corporation 江苏代理, Bio/Data Corporation 浙江代理, Bio/Data Corporation 四川代理,

http://www.biodatacorp.com

Bio/Data Corporation supports the physicians, scientists, medical technologists and technicians in laboratories around the world who work to develop groundbreaking products that lead to a better understanding of hemostasis, thrombosis, and plaet function. We are proud to support their work discovering better treatments that improve the quality of patients’ lives.

We are singularly focused on creating instruments, technologies and reagents that provide medical professionals with reliable test results for assessing various stages of hemostasis and plaet function disorders, including von Willebrand Disease and Glanzmann’s Disease, and to monitor the use of anti-plaet drugs like Plavix® and aspirin.

Founded in 1969, Bio/Data Corporation pioneered the use of optical and kinetic clot detection for Coagulation Analyzers and introduced the first automated plaet aggregometer in 1974. We continued to lead the industry by introducing the first dual channel plaet aggregometer and marketing a complete line of aggregation reagents. We also launched the first von Willebrand (vW) Factor Assay® kit.

Bio/Data Corporation also introduced the first 4-channel Plaet Aggregometer “model PAP-4” capable of performing chromogenic assays and plaet aggregration on micro-volume samples. Today our top of the line PAP-8EPlaet Aggregometer offers 8 channels, standard micro-volumes, touch screen simplicity, and an enhanced Ristocetin CoFactor assaywith multipoint standard curves.

We patented Cross Flow FiltrationTechnology which was used to create the first microsample coagulation analyzer that produced plasma without centrifugation.

Bio/Data Corporation currently holds more than a dozen US patents and numerous international patents. We have developed sophisticated software solutions and expanded our capabilities to include numerous plaet function testing applications. Today, we continue to develop new instruments, software, reagents, and technologies for clinical, research, analytical and bio-tech laboratories as well as for clinical research trials.

上海金畔生物科技有限公司